Clinical Trial Update: The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy of a phosphatidylserine-omega-3 supplement in elderly memory-impaired subjects. Results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Memory Impairment

Drugs mentioned

• Phosphatidylserine-Omega-3 (phosphatidylserine omega-3 fatty acid combination)

Snippet

Sponsor: Enzymotec | Conditions: Memory Impairment | Phase 4 | Status: COMPLETED | Results posted: 2010-03-24